BS

Danone SAFRA Danone Stock Report

Last reporting period 30 Jun, 2024

Updated 21 Oct, 2024

Last price

Market cap $B

47.106

Mega

Exchange

XFRA - Deutsche Boerse AG

BSN.F Stock Analysis

BS

Avoid

Based on Eyestock quantitative analysis, BSN.F`s fundamental data and valuation indicate an investment grade of Avoid at the current time.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

21/100

Low score

Upside

To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.

-43.5 %

Greatly overvalued

Market cap $B

47.106

Dividend yield

6.90 %

Shares outstanding

639.61 B

Danone SA engages in the food processing industry. The company is headquartered in Paris, Ile-De-France and currently employs 96,166 full-time employees. The company operates through four segments: Essential Dairy and Plant-Based Products (EDP), Waters and Specialized Nutrition, including Early Life Nutrition and Medical Nutrition. EDP produces and distributes fresh fermented dairy products and other dairy specialties, plant-based products and beverages, coffee creamers and organic products; Waters sells bottled water and water sold in small and large containers; Early Life Nutrition offers baby formula (infant milk formula, follow-on milk, growing up milks), milk and fruit-based desserts, cereals, jars of baby food and ready-made baby food; Advanced Medical Nutrition offers adult or pediatric clinical nutrition products to be taken orally or through a tube in the event of malnutrition related to illness or other causes. The Company’s brands portfolio includes Activia, Actimel, Alpro, Danette, Danonino, Danio, evian, Volvic, Nutrilon/Aptamil, Nutricia, among others.

View Section: Eyestock Rating